Clinical Trial

Active Post-Market Surveillance of Innovative Devices for Valvular Heart Disease

Name: Active Post-Market Surveillance of Innovative Devices for Valvular Heart Disease — clinical trial record (NCT07605624)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

This prospective, multicenter, observational cohort study aims to establish a post-market registry framework to evaluate the real-world clinical applicability, long-term safety, and effectiveness of innovative heart valve devices in China.

Trial Details

NCT Number	NCT07605624
Lead Sponsor	Beijing Anzhen Hospital
Conditions	Aortic Stenosis, Aortic Regurgitation, Mitral Regurgitation, Tricuspid Regurgitation
Enrollment	5,500 participants
Start Date	2026-05-10
Primary Completion	2029-01-31 (estimated)
Study Completion	2029-01-31 (estimated)
Updated on ClinicalTrials.gov	2026-05-26